Regulation of RPA Activity in DNA Repair

DNA 修复中 RPA 活性的调节

• 批准号: 7810607
• 负责人: JAMES A. BOROWIEC
• 金额: $ 33.46万
• 依托单位: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-05-01 至 2013-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7810607
• 关键词: BRCA2 gene; Binding; Cell Cycle; Cell Cycle Progression; Charge; Complex; Cultured Cells; Cyclin A; Cyclins; DNA; DNA Damage; DNA Repair; DNA Repair Pathway; DNA Replication Damage; DNA biosynthesis; DNA lesion; DNA replication fork; Data; Development; Event; Genetic Recombination; Genotoxic Stress; Goals; Human; In Vitro; Laboratories; Lead; Malignant Neoplasms; Mediator of activation protein; Mitosis; Mitotic; Modification; Molecular; Mutation; Pathway interactions; Phosphorylation; Phosphorylation Site; Phosphotransferases; Physiological; Positioning Attribute; Proteins; Reaction; Recruitment Activity; Regulation; Reporting; Role; SS DNA BP; Site; Solutions; Stress; Structure; System; Testing; Tumor Suppressor Proteins; Variant; Work; base; biological adaptation to stress; design; experience; helicase; homologous recombination; in vivo; insight; mutant; public health relevance; recombinational repair; replication factor A; research study; response; synthetic construct

DESCRIPTION (provided by applicant): The goal of this proposal is to understand the role of phosphorylation of the middle subunit (RPA2) of the heterotrimeric human replication protein A (RPA; the eukaryotic single-stranded DNA-binding protein). Recent data arising from my laboratory indicates that RPA2 phosphorylation provides an important regulatory control over the cellular DNA damage response. Using a combination of approaches, we will characterize the role of RPA phosphorylation in vivo and in vitro. Specifically, we will examine the molecular basis by which hypo-phosphorylated RPA selectively associates with the replication fork, by characterization of its interaction with the MCM complex. The association of RPA with MCM will be examined, both in solution, and on synthetic DNA replication fork structures. Second, using a RPA2 replacement strategy, we will examine the effect of RPA2 phosphorylation site mutation on the loading of the recombination mediator BRCA2 and homologous recombination factors to sites of DNA replication stress and DNA damage. The effects of RPA2 mutation on BRCA2 loading in vitro and on HR rates in vivo will be determined. Third, we have found that the synergistic activity of these kinases towards RPA2 under genotoxic stress conditions modulate subsequent phosphorylation events both on the same RPA molecule (the cis pathway) and on different RPA molecules (the trans pathway). By exploring the cis pathway, we will test the hypothesis that S33 phosphorylation facilitates recruitment of cyclin A-Cdk2 to the RPA substrate in vitro. To examine the trans reaction, we will examine the effect of RPA phosphorylation on ATR dynamics in vivo. The data generated will provide insights into how cell cycle position causes DNA lesions to be channeled into different DNA repair pathways. PUBLIC HEALTH RELEVANCE: We will understand the functional significance of RPA phosphorylation in the cellular response to DNA damage. The results from this work could lead to new threraputics to treat human cancers

描述（由申请人提供）：本提案的目标是了解异三聚体人复制蛋白A （RPA；真核生物单链dna结合蛋白）中间亚基（RPA2）磷酸化的作用。我的实验室最近的数据表明，RPA2磷酸化对细胞DNA损伤反应提供了重要的调节控制。通过多种方法的结合，我们将描述RPA磷酸化在体内和体外的作用。具体来说，我们将通过表征低磷酸化的RPA与MCM复合物的相互作用来研究其选择性与复制叉相关联的分子基础。RPA与MCM的关联将在溶液和合成DNA复制叉结构中进行检查。其次，使用RPA2替代策略，我们将检查RPA2磷酸化位点突变对重组介质BRCA2和同源重组因子加载到DNA复制应激和DNA损伤位点的影响。RPA2突变对体外BRCA2负荷和体内HR率的影响将被确定。第三，我们发现在基因毒性应激条件下，这些激酶对RPA2的协同活性调节了随后在同一RPA分子（顺式途径）和不同RPA分子（反式途径）上的磷酸化事件。通过探索顺式通路，我们将在体外验证S33磷酸化促进细胞周期蛋白A-Cdk2募集到RPA底物的假设。为了研究反式反应，我们将研究RPA磷酸化对体内ATR动力学的影响。所产生的数据将为细胞周期位置如何导致DNA损伤进入不同的DNA修复途径提供见解。